A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2004
11/17/2004	CN1175892C Sun-shielding cream and manufacturing method thereof
11/17/2004	CN1175890C Mastoproliferation treating medicine
11/17/2004	CN1175883C Scorpion medicament for treating psoriasis and its producing method
11/17/2004	CN1175878C Traditional Chinese herbal medicine for treating frostbite
11/17/2004	CN1175871C Chinese traditional medicine for treating deep ulcer and bedsore
11/17/2004	CN1175858C Chinese medicinal tincture for treating burn and scald and its preparing method
11/17/2004	CN1175850C Medicine for treating burns and scalds, and producing method thereof
11/17/2004	CN1175844C Externally-applied medicine for treating acute inflammatory disease of skin and parenchyma
11/17/2004	CN1175841C Antipruritic traditional medicine for treating tinea
11/17/2004	CN1175807C Disulfide derivatives useful for treating allergic diseases
11/16/2004	US6818761 Comprises heteropolypolysaccharide composed of alternating straight and branched portions consisting of partially acetylated and methylated galacturonic acid residues linked to rhamnose, arabinose and galactose
11/16/2004	US6818750 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders
11/16/2004	US6818658 Treating obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
11/16/2004	US6818657 Bioprecursors of a retinoic derivative and pharmaceutical and/or cosmetic compositions
11/16/2004	US6818652 Heterocyclic retinoid compounds
11/16/2004	US6818651 Antiinflammatory, antiasthmatic, skin, and autoimmune disorders; crohn*s disease, ulcerative colitis, conjuctivitis, multiple sclerosis, and rheumatoid arthritis; chronic obstructive pulmonary disease
11/16/2004	US6818638 Melvinolin derivatives
11/16/2004	US6818632 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia
11/16/2004	US6818621 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
11/16/2004	US6818447 Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor
11/16/2004	US6818419 IRAK-4: compositions and methods of use
11/16/2004	US6818232 Oat extracts: refining, compositions and methods of use
11/16/2004	US6818230 Antiproliferative effect can be achieved by subjecting conditioned medium obtained by culturing the structures of the invention in culture medium to filtration; anticancer agents
11/16/2004	US6818214 Modulating cell proliferation or apoptosis comprising modulating psoriastatin activity
11/16/2004	US6818205 Use of fluorescent whitening agents
11/16/2004	CA2159109C Therapeutic uses of keratinocyte growth factor
11/12/2004	WO2004100889A2 Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin
11/11/2004	WO2004096862A2 Improved extration and purification method for cereal beta (1-3) beta (1-4) glucan
11/11/2004	WO2004096367A1 A wound-cover material containing radical scavengers
11/11/2004	WO2004096273A1 Methods for treating interleukin-6 related diseases
11/11/2004	WO2004096261A1 Method of preparing an aqueous solution of cyclosporin-a and resulting aqueous solution
11/11/2004	WO2004096258A1 Compositions and methods for treatment of psoriasis
11/11/2004	WO2004096248A2 Composition and use of pure iodine dissolved in essential oil of melaleuca alternifolia and/or melaleuca quinquenervia
11/11/2004	WO2004096246A1 Antiallergic composition
11/11/2004	WO2004096242A1 Pharmaceutical compositions comprising cereal beta (1-3) beta (1-4) glucan
11/11/2004	WO2004096222A1 Use of 1-(5-isoquinolinesulfonyl)homopiperazine, its active metabolites, isomers and salts for treating and preventing hypopigmentary disorders
11/11/2004	WO2004096216A2 Use of a topical medicament comprising riluzole
11/11/2004	WO2004083231A3 Use of peptide ligands for plasma membrane receptors or similar for mitochondrial activity modulation
11/11/2004	WO2004073743A3 Use of a volatile liquid at atmospheric pressure and ambient temperature for the production of pharmaceutical or biological compositions
11/11/2004	WO2004073597A3 Bioadhesive liquid composition which is substancially free of water
11/11/2004	WO2004038407A3 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 12 (gpr12)
11/11/2004	WO2004026844A9 Methods and compositions of novel triazine compounds
11/11/2004	WO2003087411A8 Method to inhibit cell growth using oligonucleotides
11/11/2004	WO2003059264A9 Methods for the induction of professional and cytokine-producing regulatory cells
11/11/2004	WO2003038052A3 Nucleic acid-associated proteins
11/11/2004	US20040225140 Pharmaceutical composition for the treatment of psoriasis and other skin diseases
11/11/2004	US20040225123 Substituted phenyl naphthalenes as estrogenic agents
11/11/2004	US20040225118 31 human secreted proteins
11/11/2004	US20040225021 Polyamine compounds and compositions for use in conjunction with cancer therapy
11/11/2004	US20040225003 4,6-Dimethyl-3-{[3'-(N,N-dimethylaminomethyl)-4-hydroxy-4'-(3''-methoxyphenyl)-cyclohexylamino]-methyl}-1H-indole 2-carboxylic acid ethyl ester or other derivatives of substituted indoles; for treatment or prevention of neurodegenerative diseases, psychological disorders, AIDS, inflammation or allergies
11/11/2004	US20040224991 Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
11/11/2004	US20040224986 Piperidinyl targeting compounds that selectively bind integrins
11/11/2004	US20040224980 Compounds used as drugs in solvents as analgesics
11/11/2004	US20040224969 Salts of substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid compounds
11/11/2004	US20040224966 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/11/2004	US20040224961 Novel thiazolo (4,5-D) pyrimidine compounds
11/11/2004	US20040224954 Substituted 1H-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds
11/11/2004	US20040224941 Carboxylic acid derivatives and drugs containing the same as the active ingredient
11/11/2004	US20040224938 Substituted benzo [b] azepin-2-one compounds
11/11/2004	US20040224929 Novel vitamin D analogs
11/11/2004	US20040224925 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
11/11/2004	US20040224924 Programming a specific course and rate for a parent drug compound's metabolism that leads to an inactive or weakly active and non-toxic metabolite when the parent drug compound is administered, comprising modifying the parent drug compound by forming one or more of a predetermined chemical arrangement
11/11/2004	US20040224911 Transporters and ion channels
11/11/2004	US20040224892 Oligosaccharides in cosmetic or dermatological compositions for stimulating adhesion of keratinocytes to major proteins of the dermoepidermal junction and restoration of epidermal cohesion
11/11/2004	US20040224877 drug delivery method of deglycosylated Vitamin D binding protein (DBP-maf) for angiogenesis inhibition; anticarcinogenic, antitumor agents
11/11/2004	US20040224314 G-protein coupled receptors
11/11/2004	US20040223988 Cosmetic composition comprising human serum albumin obtained from transgenic non-human animals
11/11/2004	US20040223932 applying an adhesive composition comprising a polymerizable monomer to an area of skin that is afflicted with acne; and allowing the monomer to polymerize to form a polymer film over said area of skin.
11/11/2004	DE102004010645A1 Kosmetikum zur Depigmentierung Cosmetic for depigmentation
11/11/2004	CA2524092A1 Composition and use of pure iodine dissolved in essential oil of melaleuca alternifolia and/or melaleuca quinquenervia
11/11/2004	CA2523577A1 Methods for treating interleukin-6 related diseases
11/11/2004	CA2523341A1 Compositions and methods for treatment of psoriasis
11/11/2004	CA2523021A1 Improved extraction and purification method for cereal beta-glucan
11/11/2004	CA2522739A1 Pharmaceutical compositions comprising cereal beta (1-3) beta (1-4) glucan
11/11/2004	CA2521152A1 Use of a topical medicament comprising riluzole
11/11/2004	CA2518947A1 Antiallergic composition
11/10/2004	EP1475806A1 Radiation protector and utilization thereof
11/10/2004	EP1475386A2 Steroid nitrates for the treatment of oxidative injury and endothelial dysfunction
11/10/2004	EP1475376A1 Hair composition containing a pyrimidine-n-oxide derivative and its use to stimulate keratinic fiberes growth and/or preventing their loss
11/10/2004	EP1475097A2 Dermatological compositions comprising an extract of achyrocline sp (marcela), uses and process for the preparation thereof
11/10/2004	EP1475091A1 Mycophenolate mofetil - high dose oral suspensions
11/10/2004	EP1475083A1 Method for producing an active ingredient concentrate, and active ingredient concentrate
11/10/2004	EP1475049A1 Microdermabrasion device
11/10/2004	EP1474445A1 Glycoisoforms of adiponectin and uses thereof
11/10/2004	EP1474438A2 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
11/10/2004	EP1474425A1 Deazapurines and uses thereof
11/10/2004	EP1474403A2 Urea derivatives and their use as vanilloid receptor antagonists
11/10/2004	EP1474395A1 Nicotinamide derivates useful as p38 inhibitors
11/10/2004	EP1474392A1 Polymorphic form xvi of fexofenadine hydrochloride
11/10/2004	EP1474182A1 Composition for skin healing comprising a chitosan hydrogel
11/10/2004	EP1474173A2 Composition and method for protecting labile active components
11/10/2004	EP1474159A2 Compositions containing oat straw and willowherb extract
11/10/2004	EP1474150A2 Use of 2-alkoxyphenyl-substituted imidazotriazinones
11/10/2004	EP1474147A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
11/10/2004	EP1474138A1 Microglia inhibitors for interrupting immune reactions induced by interleukin 12 and ifn$g(g)
11/10/2004	EP1474137A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
11/10/2004	EP1474136A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
11/10/2004	EP1474127A1 Biphenyl derivatives and their use as antiandrogenic agents
11/10/2004	EP1474122A2 Compounds for blocking androgen receptors
11/10/2004	EP1474101A1 Anti-microbial composition comprising a metal ion chelating agent

1 ... 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 ... 1065